Literature DB >> 3889246

Cell proliferation within Bowman's capsule in mice.

A R Morley, J Wheeler.   

Abstract

Crescentic glomerulonephritis in man, irrespective of aetiology, indicates severe glomerular damage and carries a poor prognosis. The importance of the presence of macrophages in the development of glomerular crescents is well established, but the contribution of cellular proliferation in both macrophages and epithelial cells has received little attention. The purpose of this investigation was to develop a model of crescentic glomerulonephritis in mice, which will be suitable for cell kinetic studies. Preliminary studies are described, involving immunization with rabbit anti-mouse glomerular basement membrane (GBM) antiserum after pre-immunization with rabbit immunoglobulin G, both with and without treatment with a fibrinolytic inhibitor, Cyklokapron. Extensive glomerular damage, with crescent formation, was induced with four daily intravenous injections of rabbit anti-mouse GBM antiserum, after pre-immunization with rabbit IgG. The effect was shown to be dose dependent and was seen within 3 days of the last injection. Linear deposits of rabbit IgG were detected in all glomeruli by immunofluorescence and both linear and granular deposits of mouse IgG were also found. There was a significant increase in glomerular size and in the numbers of cells in Bowman's capsule (P less than 0.01), and increases in mitotic indices to 0.8 per cent were seen by day 13.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3889246     DOI: 10.1002/path.1711450405

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  8 in total

1.  Role of mesangial fibrinogen deposition in the pathogenesis of crescentic Henoch-Schonlein nephritis in children.

Authors:  J I Shin; J M Park; Y H Shin; J S Lee; H J Jeong
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

2.  Invariant natural killer T cells and TGF-beta attenuate anti-GBM glomerulonephritis.

Authors:  Laurent Mesnard; Alexandre C Keller; Marie-Laure Michel; Sophie Vandermeersch; Cédric Rafat; Emmanuel Letavernier; Yves Tillet; Eric Rondeau; Maria C Leite-de-Moraes
Journal:  J Am Soc Nephrol       Date:  2009-05-21       Impact factor: 10.121

3.  Anti-glomerular basement membrane (GBM) glomerulonephritis in the mouse: development of disease and cell proliferation.

Authors:  J Wheeler; A R Morley; D R Appleton
Journal:  J Exp Pathol (Oxford)       Date:  1990-06

4.  Pathological studies on nephrotoxic serum nephritis accelerated with rabbit gamma-globulin in mice.

Authors:  T Nose; K Tsurumi; K Kawada; H Nagai; H Yamada; I Yakuo; A Ojima; A Koda
Journal:  Inflammation       Date:  1989-08       Impact factor: 4.092

5.  In vivo bromodeoxyuridine incorporation in normal mouse kidney: immunohistochemical detection and measurement of labelling indices.

Authors:  H Robertson; J Wheeler; A R Morley
Journal:  Histochem J       Date:  1990-04

6.  Anti-glomerular basement membrane glomerulonephritis (anti-GBM GN) in the mouse: BrdU-labelling indices and histological damage.

Authors:  J Wheeler; H Robertson; A R Morley; D R Appleton
Journal:  Int J Exp Pathol       Date:  1993-02       Impact factor: 1.925

7.  RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis.

Authors:  C M Lloyd; A W Minto; M E Dorf; A Proudfoot; T N Wells; D J Salant; J C Gutierrez-Ramos
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

8.  Selective pharmacological inhibition of DDR1 prevents experimentally-induced glomerulonephritis in prevention and therapeutic regime.

Authors:  Solange Moll; Yukari Yasui; Ahmed Abed; Takeshi Murata; Hideaki Shimada; Akira Maeda; Naoshi Fukushima; Masakazu Kanamori; Sabine Uhles; Laura Badi; Thomas Cagarelli; Ivan Formentini; Faye Drawnel; Guy Georges; Tobias Bergauer; Rodolfo Gasser; R Daniel Bonfil; Rafael Fridman; Hans Richter; Juergen Funk; Marcus J Moeller; Christos Chatziantoniou; Marco Prunotto
Journal:  J Transl Med       Date:  2018-06-01       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.